2025-05-02 04:54:33
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Krebs Biochemicals and Industries Ltd Q4FY22 loss at Rs. 11.31 crores
Posted On : 2022-05-23 15:23:56( TIMEZONE : IST )
Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 19.9503 crores during the period ended March 31, 2022 as compared to Rs. 22.0113 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -11.3139 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. -12.9409 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -5.39 for the period ended March 31, 2022 as compared to Rs. -6 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 19.9503 crs | ₹22.0113 crs |  -9.36% |
| Net Profit | ₹-11.3139 crs | ₹-12.9409 crs |  12.57% |
| EPS | ₹-5.39 | ₹-6 | 10.17% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 19.9503 crores during the period ended March 31, 2022 as compared to Rs.16.3034 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-11.3139 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-6.9866 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-5.39 for the period ended March 31, 2022 as compared to Rs.-3.47 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 19.9503 crs | ₹16.3034 crs |  22.37% |
| Net Profit | ₹-11.3139 crs | ₹-6.9866 crs |  61.94% |
| EPS | ₹-5.39 | ₹-3.47 | 55.33% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.60.8589 crores during the Financial Year ended March 31, 2022 as compared to Rs.54.3217 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-44.5268 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-28.3586 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.-20.81 for the Financial Year ended March 31, 2022 as compared to Rs.-14.37 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹60.8589 crs | ₹54.3217 crs | 12.03% |
| Net Profit | ₹-44.5268 crs | ₹-28.3586 crs | 57.01% |
| EPS | ₹-20.81 | ₹-14.37 | 44.82% |
Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 129.40 as compared to the previous close of Rs. 122.50. The total number of shares traded during the day was 412 in over 21 trades.
The stock hit an intraday high of Rs. 129.80 and intraday low of 127.70. The net turnover during the day was Rs. 52975.00.
